2001
The changes of biological markers and treatment efficacy in schizophrenia/Abstract/
ČEŠKOVÁ, Eva, Pavel DRYBČÁK, Petr HROBAŘ, Miroslav LORENC, Hana PROCHÁZKOVÁ et. al.Základní údaje
Originální název
The changes of biological markers and treatment efficacy in schizophrenia/Abstract/
Název česky
Změny biologických markerů při účinné léčbě schizofrenie
Název anglicky
The changes of biological markers and treatment efficacy in schizophrenia /Abstract/
Autoři
ČEŠKOVÁ, Eva (203 Česká republika, garant), Pavel DRYBČÁK, Petr HROBAŘ (203 Česká republika), Miroslav LORENC, Hana PROCHÁZKOVÁ a Josef ŠPAČEK
Vydání
Progres in Psychopharmacology Biological Psychiatry" Kanada, Pergamon Press, 2001, 0278-5846
Další údaje
Jazyk
čeština
Typ výsledku
Článek v odborném periodiku
Obor
30000 3. Medical and Health Sciences
Stát vydavatele
Česká republika
Utajení
není předmětem státního či obchodního tajemství
Impakt faktor
Impact factor: 1.058
Kód RIV
RIV/00216224:14110/01:00002618
Organizační jednotka
Lékařská fakulta
UT WoS
000167596500003
Klíčová slova anglicky
biological markers; schizophrenia; outcome; neuropsychology
Změněno: 22. 6. 2009 13:56, prof. MUDr. Eva Češková, CSc.
V originále
In a group of schizophrenic patients , the effect and selected parameters of biological markers were evaluated during the index hospitalisation in the acute phase of schizophrenia (n=30) and then after one year of ambulatory treatment. After one year an average tendency towards clinical improvement and positive shifts in some objective parameters were found. The comparison between the successfully and the unsuccessfuly treated patients after the period of one year confirmed that the negative symptomatology and some easily available, in terms of time and resources undemanding parameters of biological markers may be important also for the long-term prognosis and the efficacy of maintenance treatment.
Anglicky
In a group of schizophrenic patients , the effect and selected parameters of biological markers were evaluated during the index hospitalisation in the acute phase of schizophrenia (n=30) and then after one year of ambulatory treatment. After one year an average tendency towards clinical improvement and positive shifts in some objective parameters were found. The comparison between the successfully and the unsuccessfuly treated patients after the period of one year confirmed that the negative symptomatology and some easily available, in terms of time and resources undemanding parameters of biological markers may be important also for the long-term prognosis and the efficacy of maintenance treatment.